Explore more publications!
Technology Center Malta
Got News to Share?

Technology Center Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Center Malta.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 8, 2025

Macaron AI's Mind Lab Sets New Benchmark with Trillion Parameter RL at 10% Cost, Now Integrated Into NVIDIA Megatron
December 8, 2025

Macaron AI's Mind Lab Sets New Benchmark with Trillion Parameter RL at 10% Cost, Now Integrated Into NVIDIA Megatron

Indeterminate GlobeNewswire
EngageLab Launches AI-Powered Customer Service Platform LiveDesk, Revolutionizing Enterprise Customer Experience
December 8, 2025

EngageLab Launches AI-Powered Customer Service Platform LiveDesk, Revolutionizing Enterprise Customer Experience

Indeterminate GlobeNewswire
Earth Rover Program تنطلق عالمياً بالتزامن مع فعاليات اليوم العالمي للتربة، وتكشف النقاب عن تطبيق Soilsmology العلمي الجديد
December 8, 2025

Earth Rover Program تنطلق عالمياً بالتزامن مع فعاليات اليوم العالمي للتربة، وتكشف النقاب عن تطبيق Soilsmology العلمي الجديد

Indeterminate GlobeNewswire
Earth Rover Program se lanza a nivel mundial en el Día Mundial del Suelo y revela el concepto científico de "Soilsmology"
December 8, 2025

Earth Rover Program se lanza a nivel mundial en el Día Mundial del Suelo y revela el concepto científico de "Soilsmology"

Indeterminate GlobeNewswire
O Earth Rover Program é lançado globalmente no Dia Mundial do Solo e revela o conceito científico de “Soilsmology”
December 8, 2025

O Earth Rover Program é lançado globalmente no Dia Mundial do Solo e revela o conceito científico de “Soilsmology”

Indeterminate GlobeNewswire
Lancement mondial du programme Earth Rover à l'occasion de la Journée mondiale des sols Dévoilement du concept scientifique de « soilsmology »
December 8, 2025

Lancement mondial du programme Earth Rover à l'occasion de la Journée mondiale des sols Dévoilement du concept scientifique de « soilsmology »

Indeterminate GlobeNewswire
Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer
December 8, 2025

Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer

Indeterminate GlobeNewswire
Humanoid Global Provides Portfolio Overview
December 8, 2025

Humanoid Global Provides Portfolio Overview

Indeterminate GlobeNewswire
IPinfo Reveals VPN Infrastructure Geolocation Mismatches in New Report
December 8, 2025

IPinfo Reveals VPN Infrastructure Geolocation Mismatches in New Report

Indeterminate GlobeNewswire
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue™, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia
December 8, 2025

Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue™, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia

Indeterminate GlobeNewswire
FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA HIDRADENITIS SUPPURATIVA TRIAL
December 8, 2025

FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA HIDRADENITIS SUPPURATIVA TRIAL

Indeterminate GlobeNewswire
EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients
December 8, 2025

EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients

Indeterminate GlobeNewswire
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
December 8, 2025

Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025

Indeterminate GlobeNewswire
Galapagos presenteerde nieuwe ATALANTA-1 celtherapiedata in MCL op ASH 2025
December 8, 2025

Galapagos presenteerde nieuwe ATALANTA-1 celtherapiedata in MCL op ASH 2025

Indeterminate GlobeNewswire
OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development
December 8, 2025

OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development

Indeterminate GlobeNewswire
OSE Immunotherapeutics annonce un amendement stratégique au partenariat avec AbbVie sur le développement d’ABBV-230
December 8, 2025

OSE Immunotherapeutics annonce un amendement stratégique au partenariat avec AbbVie sur le développement d’ABBV-230

Indeterminate GlobeNewswire
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
December 8, 2025

ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL

Indeterminate GlobeNewswire
ASH 2025 : Cellectis présente son plan de développement pour renforcer les taux de réponse élevés obtenus avec éti-cel dans le LNH en rechute ou réfractaire
December 8, 2025

ASH 2025 : Cellectis présente son plan de développement pour renforcer les taux de réponse élevés obtenus avec éti-cel dans le LNH en rechute ou réfractaire

Indeterminate GlobeNewswire
Epson creates 150 new jobs in Latvia with the opening of its new European Business Services centre
December 8, 2025

Epson creates 150 new jobs in Latvia with the opening of its new European Business Services centre

Indeterminate GlobeNewswire
“Epson” rada 150 jaunas darbavietas Latvijā, atklājot jauno Eiropas Biznesa pakalpojumu centru
December 8, 2025

“Epson” rada 150 jaunas darbavietas Latvijā, atklājot jauno Eiropas Biznesa pakalpojumu centru

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions